4CT-40453-14951
2 vaccinations
0 coded responses
21 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 470 / IN
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Pfizer-BioNTech
- 2021-01-16
- 2021-01-17
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · HeadacheAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-23
- 2021-01-30
- 2021-02-06
-
2021-02-07
Dose 2 — Pfizer-BioNTech
- 2021-02-07
- 2021-02-08
- 2021-02-10
- 2021-02-11
- 2021-02-13
- 2021-02-14
- 2021-02-21
- 2021-02-28
- 2021-03-07
- 2021-03-14
- 2021-03-23
- 2021-05-11
- 2021-08-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-07 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-22 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.